Navigation Links
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Date:10/12/2007

brands," stated John P. McLaughlin, chief executive officer of Anesiva. "We are confident in the ability of our talented commercial team to launch Zingo successfully and to develop a profitable franchise."

In related news, James Z. Huang has relocated to the east coast for personal reasons and will transition to a consulting role from his position as president. Mr. Huang, who joined Anesiva in September 2002 as vice president, business development & commercial operations, will remain very involved in the company's commercialization efforts.

During the meeting, Anesiva will review many parallel activities currently underway to prepare the market for Zingo, including:

-- Outreach to target hospitals to create "Zingo advocates" on the

medical and nursing staff who will support formulary acceptance.

-- Design and impending launch of http://www.manageivpain.com, a website

that targets nurses with the goal of encouraging them to focus on the

management of IV pain.

-- Creation and promotion of RNvoice -- an organization of influential

nurses with a passion for reducing pediatric needlestick pain.

-- Creation of educational and selling tools for use by sales teams.

-- Maximizing public relations initiatives through multiple channels to

raise awareness of Zingo.

The company will re-affirm its prior guidance that Zingo will likely be priced in the range of $12 - $16 per unit.

Fosun Joint Venture To Facilitate Automated Manufacturing, Increased Capacity and Cost of Goods Improvements

Anesiva will also provide information about its joint venture with Wanbang Biopharma, a Fosun company, of XuZhou, China to establish additional manufacturing capacity for worldwide supply. The additional capacity will supplement the capacity provided by automated manufacturing operations currently being qualified in the US. The C
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Doyle outlines spending for Medical College, UWM
2. Kanavas outlines new Invest Wisconsin agenda
3. UW stem cell guru outlines scientific and political future
4. Three Wisconsin approaches to technology transfer and commercialization
5. Medical College gets support to expand technology commercialization
6. Genzyme acquistion of Bone Care approved, significant impact forecast
7. A New C-Terminal GST Vector for Protein Production in S. pombe
8. Safe Production of High-Titer Retrovirus
9. Production of Full-Length, Biologically Active MEK1WT and MEK1CA
10. Yeast Protein Production System Features High Yields and One-Step Purification
11. Identification of Differentially Expressed Gene Products with the CastAway System*
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 2014 Date: Friday, April 11, 2014 ... Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... national nonprofit organization solely dedicated to finding a cure ... for those affected worldwide, will host its annual Crystal ... in Warrington, Pa. , Each year, the Crystal ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... has initiated coverage of Alliqua, Inc. (OTCQB: ALQA). ... manufacturing, and marketing proprietary products to serve the ... http://equitiesiq.com/reports/alliqua/ , In late 2012, Alliqua was ... which launched the company’s new strategy to become ...
(Date:1/14/2014)... Jan. 14, 2014  RXi Pharmaceuticals Corporation ... discovering, developing and commercializing innovative therapies addressing ... today announced that it received the Notice ... and Trademark Office on its unique self-delivering ... fibrosis. The patent covers the use of ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 During the ... is now known as “The Doctor’s Plague.” In this ... to wash their hands. This led, at times, to ... medical interns and hospital staff today don’t know that ... patients. The CBCD explains. , A study showed that ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... 23, 2011 Novavax, Inc. (Nasdaq: NVAX ) ... results in a press release to be issued after 8:00 ... hold an investor conference call at 10:00 a.m. The call ... Dr. Rahul Singhvi and other members of senior management. The ...
... SA , a Swiss-based biotechnology company with technologies for ... stable mammalian cell lines for therapeutic ... sequencing of their proprietary Chinese hamster ovary (CHO) cell ... performed in collaboration with the Institute of Biotechnology ...
... MARLBOROUGH, Mass., March 23, 2011 Advanced Cell Technology, ... a leader in the field of regenerative medicine, announced ... allowed the Company,s patent application to provide broad intellectual ... preparations of retinal pigment epithelial (RPE) cells from human ...
Cached Biology Technology:Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome 2Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome 3Selexis SA and the University of Lausanne Announce the Complete Sequencing of the Selexis SURE CHO-M Genome 4ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China 2ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China 3
(Date:4/15/2014)... Center in Greenbelt, Md., is home to hundreds ... At Goddard, some of the most cutting-edge Earth ... of that cutting-edge innovation has earned a Goddard ... Society for Anthropology and Geography awards the Vega ... has shown excellence in the fields of physical ...
(Date:4/15/2014)... study of nearly 1,000 mother-child pairs, researchers from ... prenatal exposure to selective serotonin reuptake inhibitors (SSRIs), ... other disorders, was associated with autism spectrum disorder ... study, published in the online edition of ... ASD and DD cases, and population-based controls, where ...
(Date:4/15/2014)... University of Missouri researchers have previously shown that a ... exercise exists. In a new study, Frank Booth, a ... found a potential link between the genetic pre-disposition for ... which mental maturation occurs. , For his study, Booth ... activity or extreme laziness. Booth then put the rats ...
Breaking Biology News(10 mins):Goddard scientist receives Vega Medal from King of Sweden 2Study: SSRI use during pregnancy associated with autism and developmental delays in boys 2Genetic pre-disposition toward exercise and mental development may be linked 2
... (Jan. 28, 2009) Virginia Commonwealth University researchers have ... in regulating mitochondria, the energy-producing machines of cells. This ... new treatments for heart disease to boost energy in ... of cancer. In the study, published online Jan. ...
... available in French . MONTREAL, ... to announce that Concordia,s Centre for Structural and Functional ... by nine universities which are part of the Cellulosic ... the conversion of agricultural waste into biofuel is being ...
... This release is available in German . ... year as a result of pneumococcal infection, which causes ... and the elderly are especially at risk. Vaccines are ... and increasing resistance to antibiotics is making treatment more ...
Cached Biology News:Deceiving cell walls 2
... analysis kit for 10 chips provides the ... analysis with the Experion automated electrophoresis system. ... 3 x 520 microliters Pro260 gel, 45 ... (10-260 kD), 400 microliters Pro260 sample buffer, ...
... original Gene Pulser apparatus and accessory modules the ... in the Gene Pulser II system, which features ... Gene Pulser II system has the dual advantages ... range of settings to target specific cell types ...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
... Pro260 reagents and supplies, for 10 ... sufficient to perform protein analysis with ... electrophoresis system. Supplied are 3 x ... Pro260 stain, 60 microliters Pro260 ladder ...
Biology Products: